Mono Pharmacare share news and announcements

NSE: MONOPHARMAPharmaceuticals & Biotechnology

₹8.50₹0.40 (4.49%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹8.90.

52-week range of traded prices to 23 Oct 2026

₹7.50Low, 10 Aug 2026₹22.05High, 28 Nov 2025

Market cap: ₹15 Cr
P/E: 42.4
P/B: 0.5
Dividend yield: Nonein the last 12 months
ROE: 1.1%
Debt to equity: 1.79
Volume, NSE: 2,000100.0% delivered

Mono Pharmacare board meetings

42 filed, newest first.

Sep 2026
- 3 Sep · Board meeting
  Outcome of Board Meeting held on September 03, 2026. (opens in a new tab)
Aug 2026
- 26 Aug · Board meeting
  To consider other business matters (opens in a new tab)
Jul 2026
- 9 Jul · Board meeting
  Board meeting to be held on July 09, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on July 16, 2026, To consider and approve the financial results for the period ended March 31, 2026 and other business matters (opens in a new tab)
- 2 Jul · Board meeting
  To consider and approve the financial results for the period ended March 31, 2026 and other business matters (opens in a new tab)
  Not held on this date
Jun 2026
- 3 Jun · Board meeting
  Outcome of Board Meeting held on Jun 03, 2026. (opens in a new tab)
May 2026
- 26 May · Board meeting
  To consider other business matters (opens in a new tab)
Mar 2026
- 30 Mar · Board meeting
  Outcome of Board Meeting held on March 30, 2026. (opens in a new tab)
- 23 Mar · Board meeting
  To consider other business matters : Resignation and Appointment of Statutory Auditor (opens in a new tab)
Feb 2026
- 16 Feb · Board meeting
  Outcome of Circular Resolution passed by Board of Directors of the Company on Monday, February 16, 2026. (opens in a new tab)
Nov 2025
- 29 Nov · Board meeting
  Financial results for the period ended September 30, 2025 AND OTHER. (opens in a new tab)
- 29 Nov · Board meeting
  Board meeting held on November 29, 2025. (opens in a new tab)
- 28 Nov · Board meeting
  Board meeting to be held on November 28, 2025 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 29, 2025, To consider and approve the financial results for the period ended September 30, 2025 and other business matters (opens in a new tab)
- 21 Nov · Board meeting
  Board meeting to be held on November 21, 2025 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 28, 2025, To consider and approve the financial results for the period ended September 30, 2025 and other business matters (opens in a new tab)
  Not held on this date
- 18 Nov · Board meeting
  Board meeting to be held on November 18, 2025 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 21, 2025, To consider and approve the financial results for the period ended September 30, 2025 and other business matters (opens in a new tab)
  Not held on this date
- 14 Nov · Board meeting
  Board meeting to be held on November 14, 2025 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 18, 2025, To consider and approve the financial results for the period ended September 30, 2025 and other business matters (opens in a new tab)
  Not held on this date
- 6 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2025 and other business matters (opens in a new tab)
  Not held on this date
Aug 2025
- 26 Aug · Board meeting
  Board meeting held on August 26, 2025. (opens in a new tab)
- 12 Aug · Board meeting
  To consider other business matters (opens in a new tab)
May 2025
- 27 May · Board meeting
  Board meeting to be held on May 28, 2025 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 30, 2025, To consider and approve the financial results for the period ended March 31, 2025 and other business matters (opens in a new tab)
- 12 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2025 (opens in a new tab)
  Not held on this date
Apr 2025
- 4 Apr · Board meeting
  Board meeting to be held on April 02, 2025 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on April 11, 2025, To consider other business matters (opens in a new tab)
Mar 2025
- 29 Mar · Board meeting
  Board meeting to be held on April 02, 2025 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on April 05, 2025, To consider other business matters (opens in a new tab)
- 28 Mar · Board meeting
  To consider other business matters (opens in a new tab)
Feb 2025
- 10 Feb · Board meeting
  Board meeting held on February 10, 2025, Considered and approved appointment of Mr. Rahul Joshi (ACS- 66206) as company secretary & compliance officer of the company. (opens in a new tab)
- 1 Feb · Board meeting
  To consider other business matters i.e. To consider and approve the appointment of Mr. Rahul Joshi (ACS-66206) as a Group Company Secretary & Compliance Officer of Mono Pharmacare Limited. (opens in a new tab)
Jan 2025
- 11 Jan · Board meeting
  OUTCOME OF BOARD MEETING (opens in a new tab)
- 11 Jan · Board meeting
  Board meeting held on January 11, 2025. (opens in a new tab)
- 3 Jan · Board meeting
  To consider other business matters i.e. To consider and approve appointment of Ms. Drashti Rohit Chande (DIN- 10380640) as an Additional Independent Director of the company. (opens in a new tab)
Nov 2024
- 14 Nov · Board meeting
  Board meeting held on November 14, 2024. (opens in a new tab)
- 6 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2024 and other business matters (opens in a new tab)
Sep 2024
- 6 Sep · Board meeting
  Board meeting held on September 06, 2024. (opens in a new tab)
Aug 2024
- 30 Aug · Board meeting
  To consider other business matters (opens in a new tab)
- 6 Aug · Board meeting
  Board meeting held on August 06, 2024. (opens in a new tab)
Jul 2024
- 30 Jul · Board meeting
  To take note of resignation of Mrs. Pooja Seth as Company Secretary and Compliance Officer of the Company and other business matters. (opens in a new tab)
May 2024
- 31 May · Board meeting
  Board meeting held on May 30, 2024. (opens in a new tab)
- 25 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2024 and other business matters (opens in a new tab)
Apr 2024
- 29 Apr · Board meeting
  Board meeting held on April 29, 2024. (opens in a new tab)
- 24 Apr · Board meeting
  To consider other business matters (opens in a new tab)
Mar 2024
- 11 Mar · Board meeting
  To consider other business matters (opens in a new tab)
Dec 2023
- 19 Dec · Board meeting
  Board meeting held on December 18, 2023. (opens in a new tab)
Nov 2023
- 14 Nov · Board meeting
  Board meeting held on November 14, 2023 for approval of unaudited financial results for the half year ended 30th September 2023. (opens in a new tab)
- 11 Nov · Board meeting
  Meeting on 14 Nov 2023: “MONO PHARMACARE LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2023 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended” (opens in a new tab)

Mono Pharmacare board meetings

Sep 2026

Aug 2026

Jul 2026

Jun 2026

May 2026

Mar 2026

Feb 2026

Nov 2025

Aug 2025

May 2025

Apr 2025

Mar 2025

Feb 2025

Jan 2025

Nov 2024

Sep 2024

Aug 2024

Jul 2024

May 2024

Apr 2024

Mar 2024

Dec 2023

Nov 2023